Eric Lefebvre has an estimated net worth of $7.67 Million. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., PLIANT THERAPEUTICS, INC., and Regado Biosciences Inc.

2023 was Eric Lefebvre's most active year for acquiring shares with 5 total transactions. Eric Lefebvre's most active month to acquire stocks was the month of December. 2021 was Eric Lefebvre's most active year for disposing of shares, totalling 5 transactions. Eric Lefebvre's most active month to dispose stocks was the month of February. 2022 saw Eric Lefebvre paying a total of $0.00 for 276,876 shares, this is the most they've acquired in one year. In 2023 Eric Lefebvre cashed out on 101,066 shares for a total of $3,027,838.14, their largest year based on trade value.